Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Argent Biopharma ( (AU:RGT) ) has issued an update.
Argent Biopharma Limited, listed on the ASX under the code RGT, has applied for quotation of an additional 1,000,000 ordinary fully paid shares. The new securities, issued on 15 January 2026 following the exercise or conversion of existing options or other convertible instruments, will expand Argent Biopharma’s listed share capital, modestly increasing liquidity and potentially enabling the company to further support its funding and operational needs.
The most recent analyst rating on (AU:RGT) stock is a Hold with a A$0.06 price target. To see the full list of analyst forecasts on Argent Biopharma stock, see the AU:RGT Stock Forecast page.
More about Argent Biopharma
Average Trading Volume: 85,449
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$5.34M
For an in-depth examination of RGT stock, go to TipRanks’ Overview page.